These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23928649)

  • 1. Do we really need continuous vancomycin infusion in neonates?
    Samiee-Zafarghandy S; van den Anker JN
    Arch Dis Child; 2013 Dec; 98(12):1023-4. PubMed ID: 23928649
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous infusion of vancomycin in neonates.
    Patel AD; Anand D; Lucas C; Thomson AH
    Arch Dis Child; 2013 Jun; 98(6):478-9. PubMed ID: 23543265
    [No Abstract]   [Full Text] [Related]  

  • 3. Vancomycin use in neonates and children: evidence-based practice is needed.
    Sammons HM; Starkey E
    Arch Dis Child; 2013 Jun; 98(6):447-8. PubMed ID: 23592728
    [No Abstract]   [Full Text] [Related]  

  • 4. Neonatal vancomycin continuous infusion: still a confusion?
    Gwee A; Cranswick N; Metz D; Coghlan B; Daley AJ; Bryant PA; Curtis N
    Pediatr Infect Dis J; 2014 Jun; 33(6):600-5. PubMed ID: 24378952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring.
    Zhao W; Lopez E; Biran V; Durrmeyer X; Fakhoury M; Jacqz-Aigrain E
    Arch Dis Child; 2013 Jun; 98(6):449-53. PubMed ID: 23254142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary: Continuous infusion of vancomycin in neonates: to use or not to use remains the question.
    Ward RM; Allegaert K; de Groot R; van den Anker JN
    Pediatr Infect Dis J; 2014 Jun; 33(6):606-7. PubMed ID: 24378934
    [No Abstract]   [Full Text] [Related]  

  • 7. Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule.
    Plan O; Cambonie G; Barbotte E; Meyer P; Devine C; Milesi C; Pidoux O; Badr M; Picaud JC
    Arch Dis Child Fetal Neonatal Ed; 2008 Nov; 93(6):F418-21. PubMed ID: 18450803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Continuous infusion of vancomycin in pediatric critical care].
    Zylbersztajn BL; Chicco P; Vega L; Centeno M; Filippini S; Ruvinsky S
    Arch Argent Pediatr; 2013; 111(1):e31-4. PubMed ID: 23381715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giving vancomycin as a continuous infusion.
    Embleton ND; Berrington J
    Arch Dis Child Fetal Neonatal Ed; 2009 May; 94(3):F233-4. PubMed ID: 19383864
    [No Abstract]   [Full Text] [Related]  

  • 10. [Continuous and intermittent infusion of vancomycin equally effective: review of the literature].
    van Maarseveen EM; Man WH; Touw DJ; Bouma AW; van Zanten AR
    Ned Tijdschr Geneeskd; 2011; 155(42):A2667. PubMed ID: 22027450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous infusion of vancomycin less effective and safe than intermittent infusion, based on pharmacodynamic and pharmacokinetic principles.
    Panday PN; Sturkenboom M
    Clin Infect Dis; 2009 Dec; 49(12):1964-5; author reply 1965. PubMed ID: 19929398
    [No Abstract]   [Full Text] [Related]  

  • 12. A higher dose of vancomycin in continuous infusion is needed in critically ill patients.
    Jeurissen A; Sluyts I; Rutsaert R
    Int J Antimicrob Agents; 2011 Jan; 37(1):75-7. PubMed ID: 21074374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of continuous infusion versus intermittent infusion of vancomycin in patients with methicillin-resistant Staphylococcus aureus.
    Jaruratanasirikul S; Julamanee J; Sudsai T; Saengsuwan P; Jullangkoon M; Ingviya N; Jarumanokul R
    J Med Assoc Thai; 2010 Feb; 93(2):172-6. PubMed ID: 20301996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can we guarantee less nephrotoxicity when vancomycin is administered by continuous infusion?
    Echeverría-Esnal D; Marín-Casino M; Retamero A; Grau S
    Int J Antimicrob Agents; 2016 Jul; 48(1):116-117. PubMed ID: 27234679
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictive performance of pharmacokinetic models for outpatients receiving vancomycin continuous infusion.
    Ng TM; Lye DC; Chan M; Tam VH
    Int J Antimicrob Agents; 2014 Feb; 43(2):197-9. PubMed ID: 24359843
    [No Abstract]   [Full Text] [Related]  

  • 16. Treating Gram-positive infections: vancomycin update and the whys, wherefores and evidence base for continuous infusion of anti-Gram-positive antibiotics.
    Chua K; Howden BP
    Curr Opin Infect Dis; 2009 Dec; 22(6):525-34. PubMed ID: 19738465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching From Intermittent to Continuous Infusion of Vancomycin in Critically Ill Patients: Toward a More Robust Exposure.
    van Maarseveen EM; Gipmans S; Vasbinder E; Petjak M; van Zanten AR
    Ther Drug Monit; 2016 Jun; 38(3):398-401. PubMed ID: 26926670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to: 'Continuous versus intermittent infusion of vancomycin in adult patients: a systematic review and meta-analysis'.
    Dong H; Zhong Y
    Int J Antimicrob Agents; 2016 Jul; 48(1):114-115. PubMed ID: 27234676
    [No Abstract]   [Full Text] [Related]  

  • 19. How to use vancomycin optimally in neonates: remaining questions.
    Jacqz-Aigrain E; Leroux S; Zhao W; van den Anker JN; Sharland M
    Expert Rev Clin Pharmacol; 2015; 8(5):635-48. PubMed ID: 26289222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of continuous-infusion vancomycin.
    DiMondi VP; Rafferty K
    Ann Pharmacother; 2013 Feb; 47(2):219-27. PubMed ID: 23386074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.